- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-75220795
Total 1085 results
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Poland, Taiwan, China, Italy, Spain, Australia, Brazil, Argentina
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
Herbert MeltzerJanssen Research & Development, LLCCompletedBipolar DisorderUnited States
-
Janssen Vaccines & Prevention B.V.CompletedCoronavirus Disease-2019 (COVID-19) PreventionSouth Africa, Brazil, Argentina, Mexico, India
-
Janssen Research & Development, LLCWithdrawn
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedMyelodysplastic Syndromes | Advanced or Refractory LeukemiaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedAlzheimer DiseaseUnited States
-
King's College LondonRecruiting
-
Janssen Research & Development, LLCActive, not recruiting
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
Janssen Sciences Ireland UCCompleted
-
Janssen Scientific Affairs, LLCApproved for marketingAdvanced Cancers and FGFR Genetic Alterations
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCTerminatedRespiratory Tract InfectionsBelgium, Czechia, Taiwan, Japan, Hungary, Thailand, United States, Germany, Korea, Republic of, Turkey, China, Spain, Brazil, Bulgaria, Malaysia, Estonia, Argentina, Poland, Israel, Italy, Latvia, Mexico, Panama, Slovakia, Sweden, Ukraine
-
Janssen Pharmaceutical K.K.Completed
-
OHSU Knight Cancer InstituteOregon Health and Science University; Janssen, LP; The Leukemia and Lymphoma...TerminatedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingCognitive Dysfunction | Dementia | Alzheimer DiseaseUnited States, Belgium, France, Japan, United Kingdom, Spain, Canada, Australia, Sweden, Netherlands
-
Aragon Pharmaceuticals, Inc.No longer availableProstatic NeoplasmsColombia, Brazil, Mexico
-
Janssen Vaccines & Prevention B.V.CompletedA Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsCOVID-19 PreventionUnited States, Germany, Brazil, Poland, South Africa
-
Janssen Research & Development, LLCCompletedAdvanced Solid NeoplasmsSpain, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen-Cilag International NVCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIB Prostate Cancer AJCC v8United States
-
Janssen Research & Development, LLCCompletedHepatitis B, ChronicFrance, Taiwan, Canada, United States, Germany, Spain, Japan, Russian Federation, Turkey, United Kingdom
-
Janssen Research & Development, LLCCompletedObesityUnited States, Belgium, United Kingdom, Sweden, Poland, Canada
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
Janssen Research & Development, LLCTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...Withdrawn
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedPain | Mononeuropathies | Neuralgia | Neuralgia, PostherpeticUnited States, Spain, Belgium, Netherlands
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellDenmark, France, Poland, Sweden
-
Janssen Research & Development, LLCTerminated
-
Janssen Research & Development, LLCCompletedHepatitis B, ChronicFrance, Germany, Spain, Poland, Belgium
-
Janssen Research & Development, LLCCompletedKidney Failure, ChronicUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedAlzheimer DiseaseFrance, Belgium, Germany, Spain, Sweden
-
Janssen Pharmaceutical K.K.CompletedProstatic NeoplasmsJapan
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedTraumatic Brain InjuryFrance, Belgium
-
University of WashingtonNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCTerminatedProstate AdenocarcinomaUnited States